secwatch.observer — SEC 8-K summary
======================================

Issuer:     Catheter Precision, Inc. (VTAK)
CIK:        0001716621
Form:       8-K
Filed at:   2024-04-02T23:59:59+00:00
Accession:  0001654954-24-004178
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Catheter Precision reports FY2023 revenue $442K; net loss ($70.6M) includes $60.9M goodwill impairment
--------------------------------------------------------------------------------

- Full-year 2023 revenue $442K vs $14K in 2022; Q4 revenue $128.8K vs zero in prior-year quarter.
- Net loss of ($70.6M) includes $60.9M one-time goodwill impairment; operating expenses $78.5M.
- Cash on hand $3.6M as of Dec 31, 2023; cash decreased $12.3M during the year.
- Clinical progress: VIVO European Registry enrolled 125 patients; LockeT initial trial >100 patients, second trial expected mid-2024.
- Intellectual property: 8 patent applications filed and 6 patents issued in 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716621/000165495424004178/0001654954-24-004178-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716621/000165495424004178/rmed_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-24-004178

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer